Knight Cancer Institute

Research Output 1966 2020

Filter
Letter
2019

Biopsy-proven thrombotic microangiopathy without schistocytosis on peripheral blood smear: A cautionary tale

Murphree, C. R., Nguyen, N. N., Shatzel, J. J., Olson, S. R., Chung, P. D., Lockridge, J. B., Andeen, N. & Deloughery, T., Jan 1 2019, In : American Journal of Hematology.

Research output: Contribution to journalLetter

Open Access
Thrombotic Microangiopathies
Biopsy

Healthcare expenditures of older patients with AML are similar between HMA and intensive induction chemotherapy

Lachowiez, C., Kearney, M., Meyers, G., Maziarz, R. & Cook, R. J., Jan 1 2019, In : Leukemia and Lymphoma.

Research output: Contribution to journalLetter

Induction Chemotherapy
Health Expenditures
Delivery of Health Care

Long-term stroke risk in meningioma patients treated with conventionally fractionated photon-based radiation therapy

McClelland, S., Mitin, T., Kubicky, C. D. & Jaboin, J., Jan 1 2019, In : Journal of Radiosurgery and SBRT. 6, 1, p. 77-79 3 p.

Research output: Contribution to journalLetter

Meningioma
Photons
Radiotherapy
Stroke

RE: A Reappraisal of Sex-Specific Cancer Survival Trends among Adolescents and Young Adults in the United States

Siegel, S. E., Coccia, P. F., Barr, R., Hayes-Lattin, B. & Bleyer, A., Jun 1 2019, In : Journal of the National Cancer Institute. 111, 6, p. 633-634 2 p.

Research output: Contribution to journalLetter

Open Access
Young Adult
Neoplasms

Reply to a. Dalla volta et al

Aggarwal, R., Huang, J., Alumkal, J., Feng, F. Y., Zhang, L., Stuart, J. M. & Small, E. J., Feb 1 2019, In : Journal of Clinical Oncology. 37, 4, p. 351-352 2 p.

Research output: Contribution to journalLetter

Reply to C.J. Sweeney et al

Parikh, R. B. & Prasad, V., Jan 1 2019, In : Journal of Clinical Oncology. 37, 19, p. 1680-1681 2 p.

Research output: Contribution to journalLetter

Reply to S. Sorscher

Innocenti, F., Ou, F. S., Qu, X., Zemla, T., Niedzwiecki, D., Tam, R., Mahajan, S., Goldberg, R. M., Bertagnolli, M. M., Blanke, C., Sanoff, H., Atkins, J., Polite, B., Venook, A. P., Lenz, H. J. & Kabbarah, O., Sep 1 2019, In : Journal of Clinical Oncology. 37, 25, p. 2291-2292 2 p.

Research output: Contribution to journalLetter

The surgical nature of radiation oncology should be better reflected in pre-residency training

McClelland, S., Brown, S. A., Ramirez-Fort, M. K., Jaboin, J. & Zellars, R. C., Sep 1 2019, In : Reports of Practical Oncology and Radiotherapy. 24, 5, p. 507-508 2 p.

Research output: Contribution to journalLetter

2018

Automated decision tree to evaluate genetic abnormalities when determining prognostic risk in acute myeloid leukemia

Watanabe-Smith, K., Druker, B., Tyner, J. & Edwards, D. K., Jul 31 2018, In : Haematologica. 103, 8, p. e351-e355

Research output: Contribution to journalLetter

Decision Trees
Acute Myeloid Leukemia
1 Citation (Scopus)

Brentuximab vedotin for frontline Hodgkin lymphoma: How much will a successful trial cost patients and payers?

Shanbhag, S. & Prasad, V., Nov 1 2018, In : European Journal of Cancer. 104, p. 252-253 2 p.

Research output: Contribution to journalLetter

Hodgkin Disease
Costs and Cost Analysis
cAC10-vcMMAE
1 Citation (Scopus)

Cost-effectiveness of nusinersen for spinal muscular atrophy: Reply

Prasad, V., Jul 1 2018, In : JAMA Pediatrics. 172, 7, p. 701-702 2 p.

Research output: Contribution to journalLetter

Spinal Muscular Atrophy
Cost-Benefit Analysis
1 Citation (Scopus)

Crossover is not associated with faster trial accrual

Chen, E. Y. & Prasad, V., Mar 1 2018, In : Annals of Oncology. 29, 3, p. 776-777 2 p., mdx821.

Research output: Contribution to journalLetter

4 Citations (Scopus)

Efficacy and toxicity of therapy immediately after treatment with nivolumab in relapsed multiple myeloma

Pianko, M. J., Funt, S. A., Page, D. B., Cattry, D., Scott, E., Ansell, S. M., Borrello, I. M., Gutierrez, M., Lendvai, N., Hassoun, H., Landgren, C. O. & Lesokhin, A. M., Jan 2 2018, In : Leukemia and Lymphoma. 59, 1, p. 221-224 4 p.

Research output: Contribution to journalLetter

1 Citation (Scopus)

Inconsistent reporting of potential conflicts of interest

Prasad, V., Jul 24 2018, In : JAMA - Journal of the American Medical Association. 320, 4, 1 p.

Research output: Contribution to journalLetter

Conflict of Interest

Inconsistent Reporting of Potential Conflicts of Interest

Prasad, V., Sep 1 2018, In : JAMA Pediatrics. 172, 9, 1 p.

Research output: Contribution to journalLetter

Conflict of Interest

Inconsistent Reporting of Potential Conflicts of Interest

Prasad, V., Oct 1 2018, In : JAMA Internal Medicine. 178, 10, p. 1424-1425 2 p.

Research output: Contribution to journalLetter

Conflict of Interest
1 Citation (Scopus)

Inconsistent Reporting of Potential Conflicts of Interest

Prasad, V., Oct 1 2018, In : JAMA oncology. 4, 10, 1 p.

Research output: Contribution to journalLetter

Conflict of Interest
2 Citations (Scopus)

In Regard to Palmer et al

McClelland, S. & Jaboin, J., Jul 15 2018, In : International Journal of Radiation Oncology Biology Physics. 101, 4, p. 999-1000 2 p.

Research output: Contribution to journalLetter

1 Citation (Scopus)

In Regard to Sura et al

McClelland, S. & Jaboin, J., Oct 1 2018, In : International Journal of Radiation Oncology Biology Physics. 102, 2, p. 468-469 2 p.

Research output: Contribution to journalLetter

2 Citations (Scopus)

In reply

Mailankody, S. & Prasad, V., Apr 1 2018, In : JAMA oncology. 4, 4, p. 586-587 2 p.

Research output: Contribution to journalLetter

1 Citation (Scopus)

In reply

Prasad, V., Kaestner, V. & Mailankody, S., Sep 1 2018, In : JAMA oncology. 4, 9, p. 1300-1301 2 p.

Research output: Contribution to journalLetter

1 Citation (Scopus)

In reply

Prasad, V. & Mailankody, S., Apr 1 2018, In : JAMA Internal Medicine. 178, 4, p. 588-589 2 p.

Research output: Contribution to journalLetter

Non-myeloablative allogeneic hematopoietic cell transplantation for relapsed or refractory waldenström macroglobulinemia: Evidence for a graft-versus-lymphoma effect

Maffini, E., Anderson, L. D., Sandmaier, B. M., Green, D. J., Storer, B. E., Niederwieser, D., Maziarz, R., Maloney, D. G. & Storb, R., Jun 3 2018, In : Haematologica. 103, 6, p. e252-e255

Research output: Contribution to journalLetter

Waldenstrom Macroglobulinemia
Cell Transplantation
Lymphoma
Transplants
Anterior Temporal Lobectomy
Temporal Lobe Epilepsy
African Americans
Therapeutics

The Radiation Safety of 5G Wi-Fi: Reassuring or Russian Roulette?

McClelland, S. & Jaboin, J., Aug 1 2018, In : International Journal of Radiation Oncology Biology Physics. 101, 5, p. 1274-1275 2 p.

Research output: Contribution to journalLetter

safety
Radiation
Safety
radiation
17 Citations (Scopus)

Total costs of chimeric antigen receptor T-cell immunotherapy

Hernandez, I., Prasad, V. & Gellad, W. F., Jul 1 2018, In : JAMA oncology. 4, 7, p. 994-996 3 p.

Research output: Contribution to journalLetter

T-Cell Antigen Receptor
Immunotherapy
Costs and Cost Analysis
2017
2 Citations (Scopus)

A further strategy to combat the high price of anticancer drugs

Prasad, V., De Jesús, K. & Mailankody, S., Oct 1 2017, In : Nature Reviews Clinical Oncology. 14, 10, 1 p.

Research output: Contribution to journalLetter

Pharmaceutical Preparations
2 Citations (Scopus)

A Model to Promote Clinicians' Understanding of the Continuum of Advance Care Planning

Izumi, S. & Fromme, E., Mar 1 2017, In : Journal of Palliative Medicine. 20, 3, p. 220-221 2 p.

Research output: Contribution to journalLetter

Advance Care Planning
Continuity of Patient Care
3 Citations (Scopus)

Clinically meaningful benefit: Real world use compared against the American and European guidelines

Dreicer, J. J., Mailankody, S., Fahkrejahani, F. & Prasad, V., Dec 1 2017, In : Blood Cancer Journal. 7, 12, 645.

Research output: Contribution to journalLetter

Guidelines
1 Citation (Scopus)
Large Granular Lymphocytic Leukemia
Hematopoiesis
Mutation
3 Citations (Scopus)

Conflicts of interest in Twitter

Kaestner, V., Brown, A., Tao, D. & Prasad, V., Sep 1 2017, In : The Lancet Haematology. 4, 9, p. e408-e409

Research output: Contribution to journalLetter

Conflict of Interest
1 Citation (Scopus)

Dabigatran reversal with idarucizumab

Radecki, R. P. & Deloughery, T., Oct 26 2017, In : New England Journal of Medicine. 377, 17, p. 1690-1691 2 p.

Research output: Contribution to journalLetter

Dabigatran
idarucizumab
4 Citations (Scopus)

Double autophagy stimulation using chemotherapy and mTOR inhibition combined with hydroxychloroquine for autophagy modulation in patients with relapsed or refractory multiple myeloma

Scott, E., Maziarz, R., Spurgeon, S., Medvedova, E., Gajewski, J., Reasor-Heard, S., Park, B., Kratz, A., Thomas, G., Loriaux, M., Cascio, M., Podolak, J., Gordon, M., Botelho, J., Stadtmauer, E., Amaravadi, R. & Vogl, D. T., Jun 26 2017, In : Haematologica. 102, 7, p. e261-e265

Research output: Contribution to journalLetter

7 Citations (Scopus)

Extended thromboprophylaxis with direct oral anticoagulants for medical patients: A systematic review and meta-analysis

Tao, D. L., Bien, J. Y., Deloughery, T. & Shatzel, J. J., Feb 2 2017, In : Blood. 129, 5, p. 653-655 3 p.

Research output: Contribution to journalLetter

Enoxaparin
Anticoagulants
1 Citation (Scopus)

Feasibility of Retrospective Pharmacovigilance Studies in Hospice Care: A Case Study of Antibiotics for the Treatment of Urinary Tract Infections

Furuno, J. P., Noble, B. N., Bearden, D. T. & Fromme, E., Apr 1 2017, In : Journal of Palliative Medicine. 20, 4, p. 316-317 2 p.

Research output: Contribution to journalLetter

Pharmacovigilance
Hospice Care
Urinary Tract Infections
Retrospective Studies
Anti-Bacterial Agents
1 Citation (Scopus)

Financial conflicts of interest among editorialists in high-impact journals

Kaestner, V. & Prasad, V., Sep 15 2017, In : Blood Cancer Journal. 7, 9, p. e611

Research output: Contribution to journalLetter

Conflict of Interest
14 Citations (Scopus)

Financial conflicts of interest among hematologist-oncologists on Twitter

Tao, D. L., Boothby, A., McLouth, J. & Prasad, V., Mar 1 2017, In : JAMA Internal Medicine. 177, 3, p. 425-427 3 p.

Research output: Contribution to journalLetter

Conflict of Interest
Oncologists
Adult T Cell Leukemia Lymphoma
Therapeutics

In reply

Mason, J., Paddock, M., Deloughery, T. & Grock, A., Nov 1 2017, In : Annals of Emergency Medicine. 70, 5, p. 754-755 2 p.

Research output: Contribution to journalLetter

2 Citations (Scopus)

In reply

Beer, T. T. & Prasad, V., Nov 1 2017, In : JAMA oncology. 3, 11, p. 1588-1589 2 p.

Research output: Contribution to journalLetter

Is it time to convert the frequency of radiotherapy in small-cell lung cancer?

Mitin, T., Farrell, M., Holland, J., Cetnar, J. & Thomas, C., Oct 1 2017, In : The Lancet Oncology. 18, 10, p. e554

Research output: Contribution to journalLetter

Small Cell Lung Carcinoma
Radiotherapy
Hematology
Industry
Medicine
3 Citations (Scopus)

Recurrent cyclin D2 mutations in myeloid neoplasms

Khanna, V., Eide, C. A., Tognon, C. E., Maxson, J., Wilmot, B., Bottomly, D., McWeeney, S., Edwards, V. D. K., Druker, B. & Tyner, J., Sep 1 2017, In : Leukemia. 31, 9, p. 2005-2008 4 p.

Research output: Contribution to journalLetter

9 Citations (Scopus)

The rising price of cancer drugs- a newold problem?

Prasad, V., Wang, R., Afifi, S. H. & Mailankody, S., Feb 1 2017, In : JAMA oncology. 3, 2, p. 277-278 2 p.

Research output: Contribution to journalLetter

Pharmaceutical Preparations
Neoplasms
1 Citation (Scopus)
Drug Approval
Publications
Food
Pharmaceutical Preparations
Neoplasms
1 Citation (Scopus)

To the editor

Friedberg, M. W., Gellad, W. F. & Prasad, V., Jul 1 2017, In : JAMA Internal Medicine. 177, 7, p. 1058 1 p.

Research output: Contribution to journalLetter

To the Editor

Redberg, R. F. & Prasad, V., Aug 24 2017, In : New England Journal of Medicine. 377, 8, p. 786-787 2 p.

Research output: Contribution to journalLetter

2016

Acute inflammatory skin reaction during neutrophil recovery after antileukemic therapy

Roengvoraphoj, M., Yan, S., Lansigan, F., Chapman, M. S. & Danilov, A., 2016, In : Cutis. 98, 4, p. E13-E15

Research output: Contribution to journalLetter

Chemotherapy-Induced Febrile Neutropenia
Sweet Syndrome
Mitoxantrone
Acute Promyelocytic Leukemia
Tretinoin

Andexanet Alfa for Factor Xa Inhibitor Reversal

Shatzel, J. J., Daughety, M. M. & DeLoughery, T. G., Dec 22 2016, In : The New England journal of medicine. 375, 25, p. 2499 1 p.

Research output: Contribution to journalLetter

Blood Coagulation
Factor Xa Inhibitors
PRT064445
14 Citations (Scopus)

Comprehensive geriatric assessment-guided therapy does improve outcomes of older patients with advanced lung cancer

Gajra, A., Loh, K. P., Hurria, A., Muss, H., Maggiore, R., Dale, W., Klepin, H. D., Magnuson, A., Lichtman, S. M., Williams, G. R., Shahrokhni, A. & Mohile, S. G., Nov 20 2016, In : Journal of Clinical Oncology. 34, 33, p. 4047-4048 2 p.

Research output: Contribution to journalLetter